307 related articles for article (PubMed ID: 16423573)
1. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
[TBL] [Abstract][Full Text] [Related]
2. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
3. Of humans and canines: Immunohistochemical analysis of PCNA, Bcl-2, p53, cytokeratin and ER in mammary tumours.
Kumaraguruparan R; Prathiba D; Nagini S
Res Vet Sci; 2006 Oct; 81(2):218-24. PubMed ID: 16740286
[TBL] [Abstract][Full Text] [Related]
4. Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues.
Donnay I; Rauïs J; Wouters-Ballman P; Devleeschouwer N; Leclercq G; Verstegen JP
J Reprod Fertil Suppl; 1993; 47():501-12. PubMed ID: 8229969
[TBL] [Abstract][Full Text] [Related]
5. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
6. Prolactin binding in benign and malignant mammary tissue of female dogs.
Rutteman GR; Willekes-Koolschijn N; Bevers MM; Van der Gugten AA; Misdorp W
Anticancer Res; 1986; 6(4):829-35. PubMed ID: 3019223
[TBL] [Abstract][Full Text] [Related]
7. Bax/bcl-2: cellular modulator of apoptosis in feline skin and basal cell tumours.
Madewell BR; Gandour-Edwards R; Edwards BF; Matthews KR; Griffey SM
J Comp Pathol; 2001; 124(2-3):115-21. PubMed ID: 11222007
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer.
Antuofermo E; Miller MA; Pirino S; Xie J; Badve S; Mohammed SI
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2247-56. PubMed ID: 17982119
[TBL] [Abstract][Full Text] [Related]
9. Expression and significance of PTEN in canine mammary gland tumours.
Qiu C; Lin D; Wang J; Wang L
Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
Amorim I; Lopes CC; Faustino AM; Pereira PD
J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evaluation of bcl-2, ER-alpha, caspase -3, -8, -9, PCNA and Ki-67 expressions in canine mammary carcinomas.
Aydogan A; Ozmen O; Haligur M; Sipahi C; Ileri D; Haligur A
Biotech Histochem; 2018; 93(4):286-292. PubMed ID: 29565181
[TBL] [Abstract][Full Text] [Related]
13. Studies on canine mammary tumours. II. Oestradiol and progesterone receptor binding capacity and histological type.
Boldizsár H; Muray T; Számel I; Szenci O; Csenki J
Acta Vet Hung; 1992; 40(1-2):89-97. PubMed ID: 1476094
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclooxygenase-2, Bcl-2 and Ki-67 in pleomorphic adenoma with special reference to tumor proliferation and apoptosis.
Aoki T; Tsukinoki K; Karakida K; Ota Y; Otsuru M; Kaneko A
Oral Oncol; 2004 Oct; 40(9):954-9. PubMed ID: 15380175
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
Gama A; Gärtner F; Alves A; Schmitt F
Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
[TBL] [Abstract][Full Text] [Related]
17. Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours.
Jakab C; Halász J; Szász AM; Kiss A; Schaff Z; Rusvai M; Gálfi P; Kulka J
J Comp Pathol; 2008 Nov; 139(4):238-45. PubMed ID: 18848337
[TBL] [Abstract][Full Text] [Related]
18. Modulatory influence of prepubertal biochanin A exposure on mammary gland differentiation and expression of estrogen receptor-alpha and apoptotic proteins.
Mishra P; Kar A; Kale RK
Phytother Res; 2009 Jul; 23(7):972-9. PubMed ID: 19170158
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein expression in benign and malignant canine mammary gland tumours.
Erginsoy SD; Sozmen M; Caldin M; Furlanello T
Res Vet Sci; 2006 Aug; 81(1):46-50. PubMed ID: 16289156
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers.
Rosa FE; Caldeira JR; Felipes J; Bertonha FB; Quevedo FC; Domingues MA; Moraes Neto FA; Rogatto SR
Hum Pathol; 2008 May; 39(5):720-30. PubMed ID: 18234277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
